Overview

Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Whether H2 receptor antagonist can prevent thienopyridine-related peptic ulcer remains unclear.
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Treatments:
Famotidine
Histamine
Histamine H2 Antagonists
Histamine phosphate